Lior Brimberg is assistant professor of neuroimmunology at the Center for Autoimmune and Musculoskeletal Disorders at the Feinstein Institutes for Medical Research in Manhasset, New York.
Lior Brimberg
Assistant professor
Feinstein Institutes for Medical Research
From this contributor
Maternal anti-brain antibodies may play a role in autism
Maternal antibodies that attack fetal brain proteins could underlie some cases of autism, says immunologist Betty Diamond.
Maternal anti-brain antibodies may play a role in autism
By
Betty Diamond, Peter Gregersen, Lior Brimberg
21 February 2012 | 6 min read
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
By
Ashley Juavinett
30 March 2026 | 8 min read
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
By
Dalmeet Singh Chawla
27 March 2026 | 5 min read
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
By
Claudia López Lloreda
26 March 2026 | 4 min read